ARGA Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,400
Closed -$755K 116
2022
Q2
$755K Hold
14,400
0.04% 57
2022
Q1
$745K Hold
14,400
0.04% 58
2021
Q4
$850K Sell
14,400
-1,999
-12% -$99K 0.05% 56
2021
Q3
$705K Sell
16,399
-854
-5% -$37.8K 0.05% 62
2021
Q2
$676K Hold
17,253
0.05% 63
2021
Q1
$625K Sell
17,253
-5,975
-26% -$212K 0.05% 65
2020
Q4
$855K Buy
23,228
+2,680
+13% +$98.3K 0.05% 65
2020
Q3
$715K Buy
+20,548
New +$720K 0.07% 63
2016
Q1
Sell
-3,057
Closed -$94K 55
2015
Q4
$94K Buy
+3,057
New +$96.2K 0.03% 50

Other funds holding PFE

ARGA Investment Management's PFE Position: Q3 2022 in Review

ARGA Investment Management sold out of Pfizer (PFE) in Q3 2022, closing a stake of 14,400 shares — an estimated $755K sold.

ARGA Investment Management first reported a position in PFE in Q4 2015 and held it in 9 quarters. The position peaked at $855K in Q4 2020. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • ARGA Investment Management reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • ARGA Investment Management sold 14,400 Pfizer shares in Q3 2022, an estimated $755K.
  • ARGA Investment Management first reported a position in Pfizer in Q4 2015 and held it in 9 quarters.
  • ARGA Investment Management's Pfizer position peaked at $855K in Q4 2020.
  • 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on ARGA Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.